Autologous Cell Therapy Product Market
Autologous Cell Therapy Product Market - Global Industry Assessment & Forecast
#
Pages:
156
Base Year:
2022
Feb - 2022
Format:
Report Code:
VMR-1298
Segments Covered
By
Source Bone Marrow, Epidermis
-
By
End User Hospitals, Ambulatory Centers, Research Centers
-
By
Application Cancer, Neurodegenerative Diseases, Wound Healing, Orthopedic, CVD, Autoimmune Diseases
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 11.69 Billion |
 Revenue 2030:
|
USD 40.77 Billion |
 Revenue CAGR
(2023 - 2030): |
16.90% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Autologous Cell Therapy Product Market Segment Analysis
- Autologous Cell Therapy Product Source Outlook (Revenue, USD Million, 2018 - 2030)
- Bone Marrow
- Epidermis
- Autologous Cell Therapy Product End User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Centers
- Research Centers
- Autologous Cell Therapy Product Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
-
North America Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
-
North America Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- U.S.
- U.S. Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- U.S. Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- U.S. Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- U.S. Autologous Cell Therapy Product Market, by Source
- Canada
- Canada Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Canada Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Canada Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Canada Autologous Cell Therapy Product Market, by Source
-
Mexico
- Mexico Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Mexico Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Mexico Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Mexico Autologous Cell Therapy Product Market, by Source
-
North America Autologous Cell Therapy Product Market, by Source
- Europe
-
Europe Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
-
Europe Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
-
Europe Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- U. K.
- U.K. Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- U.K. Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- U.K. Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- U.K. Autologous Cell Therapy Product Market, by Source
- France
- France Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- France Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- France Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- France Autologous Cell Therapy Product Market, by Source
-
Germany
- Germany Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Germany Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Germany Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Germany Autologous Cell Therapy Product Market, by Source
-
Italy
- Italy Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Italy Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Italy Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Italy Autologous Cell Therapy Product Market, by Source
-
Spain
- Spain Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Spain Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Spain Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Spain Autologous Cell Therapy Product Market, by Source
-
Rest of Europe
- Rest of Europe Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Rest of Europe Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Rest of Europe Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Rest of Europe Autologous Cell Therapy Product Market, by Source
-
Europe Autologous Cell Therapy Product Market, by Source
- Asia Pacific
-
Asia Pacific Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
-
Asia Pacific Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
-
Asia Pacific Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- China
- China Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- China Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- China Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- China Autologous Cell Therapy Product Market, by Source
- Japan
- Japan Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Japan Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Japan Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Japan Autologous Cell Therapy Product Market, by Source
-
Germany
- Germany Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Germany Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Germany Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Germany Autologous Cell Therapy Product Market, by Source
-
India
- India Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- India Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- India Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- India Autologous Cell Therapy Product Market, by Source
-
South Korea
- South Korea Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- South Korea Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- South Korea Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- South Korea Autologous Cell Therapy Product Market, by Source
-
South East Asia
- South East Asia Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- South East Asia Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- South East Asia Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- South East Asia Autologous Cell Therapy Product Market, by Source
-
Rest of Asia Pacific
- Rest of Asia Pacific Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Rest of Asia Pacific Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Rest of Asia Pacific Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Rest of Asia Pacific Autologous Cell Therapy Product Market, by Source
-
Asia Pacific Autologous Cell Therapy Product Market, by Source
- Latin America
-
Latin America Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
-
Latin America Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
-
Latin America Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Brazil
- Brazil Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Brazil Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Brazil Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Brazil Autologous Cell Therapy Product Market, by Source
- Argentina
- Argentina Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Argentina Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Argentina Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Argentina Autologous Cell Therapy Product Market, by Source
-
Rest of Latin America
- Rest of Latin America Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Rest of Latin America Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Rest of Latin America Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Rest of Latin America Autologous Cell Therapy Product Market, by Source
-
Latin America Autologous Cell Therapy Product Market, by Source
- Middle East & Africa
-
Middle East & Africa Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
-
Middle East & Africa Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
-
Middle East & Africa Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- GCC Countries
- GCC Countries Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- GCC Countries Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- GCC Countries Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- GCC Countries Autologous Cell Therapy Product Market, by Source
- South Africa
- South Africa Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- South Africa Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- South Africa Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- South Africa Autologous Cell Therapy Product Market, by Source
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Autologous Cell Therapy Product Market, by Source
- Bone Marrow
- Epidermis
- Rest of Middle East & Africa Autologous Cell Therapy Product Market, by End User
- Hospitals
- Ambulatory Centers
- Research Centers
- Rest of Middle East & Africa Autologous Cell Therapy Product Market, by Application
- Cancer
- Neurodegenerative Diseases
- Wound Healing
- Orthopedic
- CVD
- Autoimmune Diseases
- Rest of Middle East & Africa Autologous Cell Therapy Product Market, by Source
-
Middle East & Africa Autologous Cell Therapy Product Market, by Source
- North America
Vantage Market
Research | 24-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Autologous Cell Therapy Product in terms of revenue?
-
The global Autologous Cell Therapy Product valued at USD 11.69 Billion in 2022 and is expected to reach USD 40.77 Billion in 2030 growing at a CAGR of 16.90%.
Which are the prominent players in the market?
-
The prominent players in the market are Vericel Corporation (US), Pharmicell Co. Inc(South Korea), Holostem Terapie Avanzate S.R.L (Italy), Lineage Cell Therapeutics Inc. (US), Opexa Therapeutics (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 16.90% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Autologous Cell Therapy Product include
- Rising Government Investments in Cell-Based Research
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Autologous Cell Therapy Product in 2022.
